Search

everythinglearnresearchcommunity

for

Search:↓

Potential compounds may inhibit hair loss by targeting a non-androgen pathway.

Potential compounds may inhibit hair loss by targeting a non-androgen pathway.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Agaricus bisporus β-Glucan particles could effectively treat cervical cancer and offer antimicrobial and antioxidant benefits.

A new treatment effectively kills antibiotic-resistant bacteria and helps wounds heal faster by boosting the immune response.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

Inhibiting plant sterols reduces grapevine pathogen reproduction.

Peptide drugs now target hard-to-reach proteins more effectively and specifically.

Upadacitinib effectively treats severe alopecia areata and is safe.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

Compound 1 showed promising anticancer activity.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Probe detects finasteride with high selectivity and low detection limit.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.